|
gptkbp:instanceOf
|
gptkb:drug
gamma-cyclodextrin derivative
|
|
gptkbp:approvalYear
|
2015
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:ATCCode
|
gptkb:M03AX18
|
|
gptkbp:brand
|
gptkb:Bridion
|
|
gptkbp:CASNumber
|
343306-79-6
|
|
gptkbp:chemicalFormula
|
C72H104Na8O48S8
|
|
gptkbp:contraindication
|
known hypersensitivity to sugammadex
|
|
gptkbp:developedBy
|
gptkb:Organon
|
|
gptkbp:drugClass
|
selective relaxant binding agent
|
|
gptkbp:eliminationHalfLife
|
2 hours
|
|
gptkbp:excretion
|
renal
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
sugammadex
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
encapsulation of steroidal neuromuscular blocking agents
|
|
gptkbp:molecularWeight
|
2178.08 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
nausea
vomiting
anaphylaxis
hypotension
hypersensitivity
bradycardia
|
|
gptkbp:synonym
|
ORG 25969
|
|
gptkbp:usedFor
|
reversal of neuromuscular blockade
reversal of rocuronium
reversal of vecuronium
|
|
gptkbp:yearOfEMAApproval
|
2008
|
|
gptkbp:bfsParent
|
gptkb:Bridion
|
|
gptkbp:bfsLayer
|
5
|